Royce & Associates’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-149,664
| Closed | -$2.46M | – | 926 |
|
|
2023
Q3 | $2.46M | Sell |
149,664
-16,250
| -10% | -$267K | 0.03% | 615 |
|
|
2023
Q2 | $3.32M | Sell |
165,914
-16,536
| -9% | -$331K | 0.03% | 582 |
|
|
2023
Q1 | $3.45M | Buy |
182,450
+100,871
| +124% | +$1.91M | 0.03% | 569 |
|
|
2022
Q4 | $1.85M | Buy |
81,579
+52,296
| +179% | +$1.19M | 0.02% | 658 |
|
|
2022
Q3 | $774K | Buy |
29,283
+12,761
| +77% | +$337K | 0.01% | 772 |
|
|
2022
Q2 | $408K | Buy |
+16,522
| New | +$408K | ﹤0.01% | 854 |
|
|
2020
Q3 | – | Sell |
-60,000
| Closed | -$2.21M | – | 1136 |
|
|
2020
Q2 | $2.21M | Hold |
60,000
| – | – | 0.02% | 648 |
|
|
2020
Q1 | $1.94M | Hold |
60,000
| – | – | 0.03% | 600 |
|
|
2019
Q4 | $2.46M | Hold |
60,000
| – | – | 0.02% | 659 |
|
|
2019
Q3 | $2.14M | Hold |
60,000
| – | – | 0.02% | 695 |
|
|
2019
Q2 | $3.08M | Buy |
60,000
+31,539
| +111% | +$1.62M | 0.03% | 614 |
|
|
2019
Q1 | $1.63M | Buy |
28,461
+88
| +0.3% | +$5.04K | 0.01% | 788 |
|
|
2018
Q4 | $1.19M | Buy |
28,373
+92
| +0.3% | +$3.86K | 0.01% | 837 |
|
|
2018
Q3 | $2.14M | Sell |
28,281
-11,933
| -30% | -$901K | 0.01% | 812 |
|
|
2018
Q2 | $2.89M | Sell |
40,214
-36,786
| -48% | -$2.64M | 0.02% | 748 |
|
|
2018
Q1 | $2.3M | Buy |
77,000
+18,000
| +31% | +$537K | 0.02% | 808 |
|
|
2017
Q4 | $1.96M | Buy |
+59,000
| New | +$1.96M | 0.01% | 854 |
|